Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

FREQ - Frequency Therapeutics Inc


Close
0.2996
0.017   5.607%

Share volume: 309,164
Last Updated: Fri 03 Nov 2023 09:00:00 PM CET
Pharmaceutical Preparation Manufacturing : -2.88%

PREVIOUS CLOSE
CHG
CHG%

$0.28
0.02
5.94%
This ticker is disabled and data are no longer maintained and up to date.
Fundamental analysis
14%
Profitability 3%
Dept financing 38%
Liquidity 41%
Performance 12%
Company vs Stock growth
vs
Performance
5 Days
29.14%
1 Month
-2.12%
3 Months
-58.68%
6 Months
-25.62%
1 Year
-87.52%
2 Year
-95.67%
Key data
Stock price
$0.30
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$0.18 - $5.59
52 WEEK CHANGE
-$0.88
MARKET CAP 
10.942 M
YIELD 
N/A
SHARES OUTSTANDING 
36.521 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.47
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$240,508
AVERAGE 30 VOLUME 
$150,940
Company detail
CEO:
Region: US
Website: frequencytx.com
Employees: 66
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Preparation Manufacturing
Sector: Manufacturing

frequency therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. through the controlled activation of progenitor cells, frequency enables disease modification without the complexity of genetic engineering. our lead program re-creates sensory cells in the inner ear to treat chronic noise induced hearing loss, which affects over 30 million people in the u.s. alone.

Recent news